The Tarcine BioMed Inc. (Tarcine) is a Sino-America joint venture company based in Beijing, China. The missions of Tarcine are：

(1) Developing novel non-invasive diagnostic or therapeutic agents through cutting edge researches of cellular, molecular and immunobiology.
　

Our company's core activities include the discovery, manufacturing and marketing of convenient and highly accurate diagnostic solutions. By utilizing patient’s urine, stool and blood specimens, Tarcine’s patented technologies will not only improve the accuracy and sensitivity of disease detection, but also increase patients’ safety and their compliancy to clinical tests.

(2) Providing pre-clinical contract service with non-human primate in the “Capital Primate Research Center” which is jointly funded and operated with the Capital Medical University.